| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cesarean Section | 26 | 2020 | 1431 | 2.880 |
Why?
|
| Disabled Persons | 9 | 2017 | 1208 | 1.970 |
Why?
|
| Pregnancy | 134 | 2023 | 30260 | 1.910 |
Why?
|
| Pregnancy Complications | 17 | 2021 | 2975 | 1.730 |
Why?
|
| Diabetes, Gestational | 21 | 2021 | 1263 | 1.520 |
Why?
|
| Pregnant Women | 5 | 2015 | 575 | 1.380 |
Why?
|
| Personal Autonomy | 7 | 2021 | 315 | 1.260 |
Why?
|
| Mobility Limitation | 5 | 2017 | 408 | 1.250 |
Why?
|
| Pregnancy Outcome | 25 | 2021 | 2966 | 1.240 |
Why?
|
| Prenatal Care | 9 | 2016 | 1160 | 1.240 |
Why?
|
| Home Childbirth | 3 | 2015 | 55 | 1.240 |
Why?
|
| Delivery, Obstetric | 14 | 2020 | 946 | 1.210 |
Why?
|
| Labor, Induced | 6 | 2020 | 153 | 1.180 |
Why?
|
| Ethics, Medical | 7 | 2017 | 783 | 1.150 |
Why?
|
| Pregnancy Complications, Cardiovascular | 9 | 2015 | 521 | 0.910 |
Why?
|
| Obstetrics | 7 | 2016 | 680 | 0.890 |
Why?
|
| Analgesia, Obstetrical | 2 | 2019 | 175 | 0.860 |
Why?
|
| Embolism, Amniotic Fluid | 2 | 2013 | 21 | 0.840 |
Why?
|
| Finger Injuries | 1 | 2023 | 146 | 0.770 |
Why?
|
| Thumb | 1 | 2023 | 233 | 0.750 |
Why?
|
| Developed Countries | 2 | 2016 | 452 | 0.720 |
Why?
|
| Fetal Macrosomia | 5 | 2013 | 139 | 0.720 |
Why?
|
| Roseolovirus Infections | 1 | 2021 | 50 | 0.710 |
Why?
|
| Herpesvirus 6, Human | 1 | 2021 | 97 | 0.690 |
Why?
|
| Ultrasonography, Prenatal | 9 | 2013 | 1774 | 0.680 |
Why?
|
| Visitors to Patients | 1 | 2020 | 36 | 0.680 |
Why?
|
| Hemorrhagic Fever, Ebola | 2 | 2015 | 424 | 0.660 |
Why?
|
| Attitude of Health Personnel | 6 | 2014 | 3925 | 0.650 |
Why?
|
| Pre-Eclampsia | 17 | 2018 | 1261 | 0.640 |
Why?
|
| Fetal Diseases | 5 | 2015 | 914 | 0.630 |
Why?
|
| Virus Integration | 1 | 2021 | 304 | 0.630 |
Why?
|
| Parturition | 5 | 2018 | 454 | 0.610 |
Why?
|
| Informed Consent | 3 | 2013 | 1010 | 0.590 |
Why?
|
| Hallucinogens | 1 | 2022 | 212 | 0.590 |
Why?
|
| Abortion, Legal | 2 | 2012 | 121 | 0.560 |
Why?
|
| Bioethical Issues | 2 | 2009 | 119 | 0.550 |
Why?
|
| Fetal Growth Retardation | 1 | 2021 | 591 | 0.540 |
Why?
|
| Dystocia | 3 | 2013 | 33 | 0.540 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2013 | 1093 | 0.540 |
Why?
|
| Risk Management | 1 | 2020 | 559 | 0.530 |
Why?
|
| Ethics, Clinical | 2 | 2008 | 101 | 0.530 |
Why?
|
| Perinatal Mortality | 2 | 2016 | 103 | 0.520 |
Why?
|
| Female | 143 | 2023 | 396112 | 0.520 |
Why?
|
| Abortion, Spontaneous | 1 | 2021 | 536 | 0.510 |
Why?
|
| Patient Preference | 2 | 2013 | 952 | 0.500 |
Why?
|
| Cannabis | 1 | 2022 | 446 | 0.500 |
Why?
|
| Decision Making | 4 | 2021 | 3965 | 0.490 |
Why?
|
| Pregnancy Trimester, First | 18 | 2018 | 919 | 0.480 |
Why?
|
| Congenital Abnormalities | 4 | 2014 | 704 | 0.470 |
Why?
|
| Sex Hormone-Binding Globulin | 5 | 2007 | 558 | 0.470 |
Why?
|
| Pregnancy, Multiple | 4 | 2009 | 216 | 0.470 |
Why?
|
| Refusal to Treat | 1 | 2014 | 43 | 0.470 |
Why?
|
| Surgical Flaps | 1 | 2023 | 1677 | 0.470 |
Why?
|
| Opiate Substitution Treatment | 1 | 2019 | 452 | 0.460 |
Why?
|
| Physicians | 5 | 2017 | 4588 | 0.460 |
Why?
|
| Moral Obligations | 1 | 2014 | 91 | 0.450 |
Why?
|
| Treatment Refusal | 4 | 2012 | 433 | 0.430 |
Why?
|
| Obstetric Labor Complications | 2 | 2009 | 240 | 0.430 |
Why?
|
| Extraction, Obstetrical | 2 | 2010 | 28 | 0.420 |
Why?
|
| Virus Replication | 1 | 2021 | 2447 | 0.420 |
Why?
|
| Postnatal Care | 1 | 2015 | 275 | 0.420 |
Why?
|
| Stereotyping | 1 | 2015 | 242 | 0.420 |
Why?
|
| Civil Rights | 1 | 2014 | 129 | 0.410 |
Why?
|
| Altruism | 1 | 2014 | 211 | 0.410 |
Why?
|
| Infection Control | 1 | 2020 | 983 | 0.410 |
Why?
|
| Heart Arrest | 2 | 2013 | 1516 | 0.410 |
Why?
|
| Gynecological Examination | 1 | 2012 | 32 | 0.400 |
Why?
|
| Physician-Patient Relations | 7 | 2017 | 3278 | 0.400 |
Why?
|
| Conflict of Interest | 1 | 2017 | 556 | 0.400 |
Why?
|
| Insulin Resistance | 10 | 2021 | 3985 | 0.400 |
Why?
|
| Humans | 151 | 2023 | 765968 | 0.390 |
Why?
|
| Mandatory Programs | 1 | 2012 | 87 | 0.380 |
Why?
|
| Patient Care | 1 | 2017 | 629 | 0.380 |
Why?
|
| Researcher-Subject Relations | 1 | 2011 | 14 | 0.380 |
Why?
|
| Therapeutic Misconception | 1 | 2011 | 10 | 0.370 |
Why?
|
| Abortion, Induced | 3 | 2013 | 471 | 0.370 |
Why?
|
| Marriage | 1 | 2013 | 351 | 0.370 |
Why?
|
| Hypertension | 11 | 2015 | 8626 | 0.360 |
Why?
|
| Maternal Health Services | 3 | 2017 | 472 | 0.360 |
Why?
|
| Midwifery | 1 | 2013 | 132 | 0.360 |
Why?
|
| Facility Regulation and Control | 1 | 2011 | 25 | 0.360 |
Why?
|
| Family Relations | 1 | 2013 | 318 | 0.360 |
Why?
|
| Prejudice | 1 | 2015 | 567 | 0.350 |
Why?
|
| Pregnancy Trimester, Second | 4 | 2016 | 737 | 0.350 |
Why?
|
| Analgesia, Epidural | 2 | 2011 | 337 | 0.350 |
Why?
|
| Neonatology | 1 | 2012 | 142 | 0.350 |
Why?
|
| Brain Death | 1 | 2014 | 360 | 0.350 |
Why?
|
| Perineum | 3 | 2004 | 213 | 0.340 |
Why?
|
| Heart Diseases | 2 | 2013 | 2821 | 0.330 |
Why?
|
| Neonatal Abstinence Syndrome | 2 | 2023 | 110 | 0.330 |
Why?
|
| Withholding Treatment | 1 | 2014 | 621 | 0.330 |
Why?
|
| Adult | 81 | 2023 | 223044 | 0.320 |
Why?
|
| Practice Management, Medical | 1 | 2011 | 191 | 0.320 |
Why?
|
| Research Subjects | 1 | 2011 | 247 | 0.310 |
Why?
|
| Parity | 11 | 2010 | 931 | 0.310 |
Why?
|
| Opioid-Related Disorders | 3 | 2023 | 2178 | 0.310 |
Why?
|
| Gynecology | 2 | 2012 | 535 | 0.310 |
Why?
|
| Vaccination | 1 | 2021 | 3426 | 0.300 |
Why?
|
| Birth Weight | 10 | 2016 | 2121 | 0.300 |
Why?
|
| Genetic Privacy | 1 | 2008 | 58 | 0.290 |
Why?
|
| Ethical Theory | 1 | 2007 | 34 | 0.290 |
Why?
|
| Antihypertensive Agents | 5 | 2015 | 2033 | 0.280 |
Why?
|
| Interpersonal Relations | 1 | 2015 | 1432 | 0.280 |
Why?
|
| Fetal Membranes, Premature Rupture | 3 | 2014 | 137 | 0.280 |
Why?
|
| Interdisciplinary Communication | 1 | 2012 | 932 | 0.270 |
Why?
|
| Fetus | 2 | 2013 | 1870 | 0.270 |
Why?
|
| Episiotomy | 3 | 2011 | 21 | 0.270 |
Why?
|
| Tissue Banks | 1 | 2007 | 183 | 0.270 |
Why?
|
| Obstetric Labor, Premature | 3 | 2016 | 268 | 0.260 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2015 | 2187 | 0.260 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2014 | 2203 | 0.260 |
Why?
|
| Natural Childbirth | 3 | 2013 | 15 | 0.250 |
Why?
|
| Glucose Intolerance | 4 | 2021 | 580 | 0.250 |
Why?
|
| Cooperative Behavior | 2 | 2012 | 1509 | 0.250 |
Why?
|
| Blood Glucose | 12 | 2021 | 6424 | 0.250 |
Why?
|
| Health Services Accessibility | 3 | 2015 | 5508 | 0.250 |
Why?
|
| Anesthesia | 2 | 2017 | 1590 | 0.250 |
Why?
|
| Embryo Transfer | 1 | 2009 | 525 | 0.240 |
Why?
|
| Wheelchairs | 2 | 2015 | 78 | 0.240 |
Why?
|
| Health Status | 2 | 2015 | 4080 | 0.240 |
Why?
|
| Risk | 8 | 2015 | 9591 | 0.230 |
Why?
|
| Catgut | 1 | 2004 | 6 | 0.230 |
Why?
|
| Patients | 1 | 2011 | 910 | 0.230 |
Why?
|
| Medicine | 1 | 2012 | 942 | 0.230 |
Why?
|
| Mothers | 1 | 2015 | 2210 | 0.230 |
Why?
|
| Physician's Role | 1 | 2011 | 927 | 0.230 |
Why?
|
| Polyglactin 910 | 1 | 2004 | 56 | 0.230 |
Why?
|
| Gestational Age | 15 | 2018 | 3609 | 0.230 |
Why?
|
| Abortion, Therapeutic | 1 | 2004 | 35 | 0.220 |
Why?
|
| Fetal Death | 4 | 2012 | 435 | 0.220 |
Why?
|
| Placenta Accreta | 3 | 2011 | 242 | 0.220 |
Why?
|
| Self Report | 1 | 2015 | 3770 | 0.220 |
Why?
|
| Placenta | 6 | 2023 | 1728 | 0.220 |
Why?
|
| Labor Presentation | 2 | 2016 | 54 | 0.220 |
Why?
|
| Metformin | 2 | 2008 | 904 | 0.220 |
Why?
|
| Chorionic Villi | 1 | 2003 | 53 | 0.220 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2012 | 1085 | 0.210 |
Why?
|
| Endocrinology | 1 | 2009 | 444 | 0.210 |
Why?
|
| Pediatrics | 4 | 2013 | 3606 | 0.210 |
Why?
|
| Pregnancy, High-Risk | 2 | 2014 | 121 | 0.210 |
Why?
|
| Hospitalization | 3 | 2015 | 10808 | 0.210 |
Why?
|
| Posture | 2 | 2019 | 954 | 0.210 |
Why?
|
| United States | 22 | 2017 | 72903 | 0.210 |
Why?
|
| Infant, Newborn | 31 | 2023 | 26346 | 0.210 |
Why?
|
| Birth Injuries | 2 | 2011 | 150 | 0.200 |
Why?
|
| Vaginal Birth after Cesarean | 2 | 2015 | 65 | 0.200 |
Why?
|
| Abortion, Eugenic | 2 | 2012 | 39 | 0.200 |
Why?
|
| Brachial Plexus | 2 | 2011 | 174 | 0.200 |
Why?
|
| Risk Assessment | 14 | 2020 | 24282 | 0.200 |
Why?
|
| Sutures | 1 | 2004 | 284 | 0.200 |
Why?
|
| Private Sector | 1 | 2005 | 396 | 0.190 |
Why?
|
| Postoperative Complications | 4 | 2019 | 15747 | 0.190 |
Why?
|
| Interviews as Topic | 4 | 2017 | 2739 | 0.190 |
Why?
|
| Gastroschisis | 2 | 2013 | 99 | 0.190 |
Why?
|
| Terminal Care | 1 | 2014 | 1774 | 0.190 |
Why?
|
| Patient Transfer | 1 | 2009 | 790 | 0.190 |
Why?
|
| Postpartum Period | 4 | 2014 | 1205 | 0.190 |
Why?
|
| Quality of Health Care | 1 | 2016 | 4300 | 0.180 |
Why?
|
| Pregnancy Trimester, Third | 4 | 2018 | 587 | 0.180 |
Why?
|
| Calcium Channel Blockers | 2 | 2015 | 686 | 0.180 |
Why?
|
| Hormone Replacement Therapy | 1 | 2007 | 753 | 0.180 |
Why?
|
| Hypoglycemia | 1 | 2008 | 896 | 0.180 |
Why?
|
| Mental Health | 1 | 2015 | 3278 | 0.180 |
Why?
|
| Pain, Postoperative | 2 | 2017 | 1772 | 0.180 |
Why?
|
| Depression | 2 | 2015 | 8237 | 0.180 |
Why?
|
| Sick Leave | 1 | 2021 | 105 | 0.170 |
Why?
|
| Placenta Previa | 2 | 2012 | 125 | 0.170 |
Why?
|
| Dandy-Walker Syndrome | 1 | 2000 | 44 | 0.170 |
Why?
|
| Embryonic Stem Cells | 1 | 2007 | 1241 | 0.170 |
Why?
|
| Mass Screening | 4 | 2019 | 5446 | 0.170 |
Why?
|
| Quality Assurance, Health Care | 1 | 2010 | 2172 | 0.170 |
Why?
|
| Labor, Obstetric | 4 | 2017 | 317 | 0.170 |
Why?
|
| Maternal Age | 3 | 2005 | 804 | 0.170 |
Why?
|
| C-Reactive Protein | 4 | 2007 | 3850 | 0.170 |
Why?
|
| Stress, Psychological | 1 | 2015 | 4533 | 0.170 |
Why?
|
| Insulin | 4 | 2016 | 6599 | 0.170 |
Why?
|
| Risk Factors | 33 | 2018 | 74840 | 0.160 |
Why?
|
| Postpartum Hemorrhage | 2 | 2013 | 276 | 0.160 |
Why?
|
| Biological Specimen Banks | 1 | 2005 | 786 | 0.160 |
Why?
|
| Counseling | 4 | 2016 | 1551 | 0.160 |
Why?
|
| Abruptio Placentae | 1 | 2020 | 115 | 0.160 |
Why?
|
| Tissue and Organ Procurement | 1 | 2007 | 989 | 0.160 |
Why?
|
| Acid-Base Equilibrium | 1 | 1999 | 180 | 0.160 |
Why?
|
| Prenatal Diagnosis | 4 | 2012 | 1268 | 0.160 |
Why?
|
| Hypoglycemic Agents | 2 | 2008 | 3110 | 0.150 |
Why?
|
| Clinical Trials as Topic | 2 | 2013 | 8041 | 0.150 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2020 | 132 | 0.150 |
Why?
|
| Weight Gain | 1 | 2009 | 2355 | 0.150 |
Why?
|
| Triplets | 1 | 1998 | 42 | 0.150 |
Why?
|
| Genetic Testing | 2 | 2010 | 3595 | 0.150 |
Why?
|
| Young Adult | 18 | 2023 | 59889 | 0.150 |
Why?
|
| Prevalence | 8 | 2021 | 15842 | 0.150 |
Why?
|
| Fetal Blood | 1 | 2005 | 1369 | 0.150 |
Why?
|
| Pregnancy Complications, Hematologic | 1 | 2020 | 183 | 0.150 |
Why?
|
| Chorion | 1 | 1998 | 113 | 0.150 |
Why?
|
| Hypertension, Pregnancy-Induced | 3 | 2013 | 532 | 0.140 |
Why?
|
| Lobbying | 1 | 2017 | 32 | 0.140 |
Why?
|
| Antithyroid Agents | 1 | 1997 | 72 | 0.140 |
Why?
|
| Breast Feeding | 2 | 2019 | 1364 | 0.140 |
Why?
|
| Socioeconomic Factors | 3 | 2015 | 7838 | 0.140 |
Why?
|
| Cervix Uteri | 1 | 2021 | 579 | 0.140 |
Why?
|
| Middle Aged | 21 | 2023 | 223009 | 0.140 |
Why?
|
| Societies | 1 | 2017 | 106 | 0.140 |
Why?
|
| Reference Values | 4 | 2011 | 4908 | 0.130 |
Why?
|
| Birthing Centers | 2 | 2009 | 12 | 0.130 |
Why?
|
| Fetal Viability | 1 | 2016 | 23 | 0.130 |
Why?
|
| Pregnancy Proteins | 4 | 2005 | 225 | 0.130 |
Why?
|
| Glucose Tolerance Test | 4 | 2021 | 1180 | 0.130 |
Why?
|
| Substance Abuse Detection | 1 | 2019 | 301 | 0.130 |
Why?
|
| Education | 1 | 2019 | 533 | 0.130 |
Why?
|
| Social Support | 2 | 2016 | 2192 | 0.130 |
Why?
|
| Societies, Medical | 2 | 2019 | 3956 | 0.130 |
Why?
|
| Puerperal Disorders | 1 | 2019 | 306 | 0.130 |
Why?
|
| Abortion, Habitual | 2 | 1994 | 65 | 0.130 |
Why?
|
| Liability, Legal | 1 | 2017 | 209 | 0.130 |
Why?
|
| Fertilization in Vitro | 1 | 2003 | 1306 | 0.120 |
Why?
|
| Infectious Disease Transmission, Professional-to-Patient | 1 | 1995 | 33 | 0.120 |
Why?
|
| Case-Control Studies | 18 | 2018 | 22223 | 0.120 |
Why?
|
| Acute Kidney Injury | 2 | 2018 | 1946 | 0.120 |
Why?
|
| Hysterectomy | 3 | 2015 | 864 | 0.120 |
Why?
|
| Africa, Western | 1 | 2015 | 160 | 0.120 |
Why?
|
| Respiratory Therapy | 1 | 2015 | 124 | 0.120 |
Why?
|
| Trial of Labor | 2 | 2007 | 85 | 0.120 |
Why?
|
| Employment | 1 | 2021 | 1106 | 0.120 |
Why?
|
| Blood Transfusion | 2 | 2011 | 1297 | 0.120 |
Why?
|
| Affect | 1 | 2002 | 1500 | 0.120 |
Why?
|
| Blood Pressure | 7 | 2018 | 8532 | 0.120 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 560 | 0.120 |
Why?
|
| Adolescent | 14 | 2023 | 88835 | 0.110 |
Why?
|
| Airway Resistance | 1 | 2015 | 407 | 0.110 |
Why?
|
| Genital Diseases, Female | 1 | 2015 | 193 | 0.110 |
Why?
|
| Hostility | 1 | 2015 | 185 | 0.110 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2019 | 1896 | 0.110 |
Why?
|
| Thyroid Diseases | 1 | 1997 | 388 | 0.110 |
Why?
|
| Infant, Small for Gestational Age | 3 | 2018 | 469 | 0.110 |
Why?
|
| Methylergonovine | 1 | 2013 | 8 | 0.110 |
Why?
|
| Exploratory Behavior | 1 | 2015 | 271 | 0.110 |
Why?
|
| Tissue Donors | 1 | 2003 | 2395 | 0.110 |
Why?
|
| Kidney Calculi | 1 | 2018 | 457 | 0.110 |
Why?
|
| Maternal Mortality | 1 | 2016 | 313 | 0.110 |
Why?
|
| Nurse Midwives | 2 | 2003 | 24 | 0.110 |
Why?
|
| Coitus | 1 | 2014 | 133 | 0.110 |
Why?
|
| Ethics, Nursing | 1 | 2013 | 24 | 0.100 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 3 | 2005 | 561 | 0.100 |
Why?
|
| Oxytocics | 1 | 2013 | 67 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 4 | 2015 | 7425 | 0.100 |
Why?
|
| Data Collection | 3 | 2013 | 3318 | 0.100 |
Why?
|
| Texas | 1 | 2014 | 410 | 0.100 |
Why?
|
| Lymphangioma, Cystic | 1 | 2012 | 34 | 0.100 |
Why?
|
| Fetal Weight | 1 | 2012 | 90 | 0.100 |
Why?
|
| Nuchal Translucency Measurement | 1 | 2012 | 59 | 0.100 |
Why?
|
| Abnormalities, Drug-Induced | 1 | 2015 | 335 | 0.100 |
Why?
|
| Reminder Systems | 1 | 2015 | 388 | 0.100 |
Why?
|
| Vagina | 2 | 1997 | 848 | 0.100 |
Why?
|
| Advance Directives | 1 | 2014 | 251 | 0.100 |
Why?
|
| Family Practice | 1 | 2015 | 508 | 0.100 |
Why?
|
| Hydrops Fetalis | 1 | 2012 | 113 | 0.100 |
Why?
|
| Cohort Studies | 19 | 2021 | 41649 | 0.100 |
Why?
|
| Retrospective Studies | 20 | 2023 | 81514 | 0.090 |
Why?
|
| Pandemics | 2 | 2022 | 8703 | 0.090 |
Why?
|
| Uterus | 3 | 2011 | 661 | 0.090 |
Why?
|
| Abnormalities, Multiple | 3 | 2013 | 1424 | 0.090 |
Why?
|
| Uterine Hemorrhage | 1 | 1992 | 235 | 0.090 |
Why?
|
| Truth Disclosure | 1 | 1995 | 433 | 0.090 |
Why?
|
| Bradycardia | 1 | 2012 | 302 | 0.090 |
Why?
|
| Morals | 1 | 2014 | 288 | 0.090 |
Why?
|
| Peer Group | 1 | 2016 | 701 | 0.090 |
Why?
|
| Labor Stage, First | 1 | 2010 | 18 | 0.090 |
Why?
|
| Follow-Up Studies | 6 | 2023 | 39193 | 0.090 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2007 | 10383 | 0.090 |
Why?
|
| Directive Counseling | 1 | 2012 | 171 | 0.090 |
Why?
|
| Body Mass Index | 9 | 2018 | 13039 | 0.090 |
Why?
|
| Labor Stage, Second | 1 | 2010 | 45 | 0.090 |
Why?
|
| Femoral Neoplasms | 1 | 2010 | 85 | 0.090 |
Why?
|
| Thoracic Vertebrae | 1 | 2014 | 614 | 0.080 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 26318 | 0.080 |
Why?
|
| Follistatin-Related Proteins | 1 | 2009 | 48 | 0.080 |
Why?
|
| Occupational Exposure | 1 | 2020 | 1805 | 0.080 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2010 | 129 | 0.080 |
Why?
|
| Odds Ratio | 7 | 2015 | 9649 | 0.080 |
Why?
|
| State Government | 1 | 2012 | 388 | 0.080 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2015 | 3230 | 0.080 |
Why?
|
| Biometry | 1 | 2012 | 571 | 0.080 |
Why?
|
| Logistic Models | 8 | 2017 | 13266 | 0.080 |
Why?
|
| Multivariate Analysis | 7 | 2017 | 12056 | 0.080 |
Why?
|
| Health Care Surveys | 2 | 2013 | 2424 | 0.080 |
Why?
|
| Qualitative Research | 2 | 2017 | 3139 | 0.080 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 1 | 2010 | 116 | 0.080 |
Why?
|
| Toll-Like Receptors | 1 | 2012 | 583 | 0.080 |
Why?
|
| Perception | 1 | 2015 | 1205 | 0.080 |
Why?
|
| Urinary Tract Infections | 1 | 2014 | 805 | 0.080 |
Why?
|
| Body Temperature | 1 | 2011 | 779 | 0.070 |
Why?
|
| Professional Autonomy | 1 | 2009 | 172 | 0.070 |
Why?
|
| Government Regulation | 1 | 2012 | 525 | 0.070 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2010 | 258 | 0.070 |
Why?
|
| Quality Indicators, Health Care | 1 | 2017 | 1806 | 0.070 |
Why?
|
| Patient Care Planning | 1 | 2013 | 906 | 0.070 |
Why?
|
| Boston | 3 | 2018 | 9338 | 0.070 |
Why?
|
| Twins | 1 | 2009 | 341 | 0.070 |
Why?
|
| Age Factors | 5 | 2021 | 18380 | 0.070 |
Why?
|
| Nuclear Transfer Techniques | 1 | 2007 | 61 | 0.070 |
Why?
|
| California | 2 | 2009 | 1436 | 0.070 |
Why?
|
| Coercion | 1 | 2007 | 68 | 0.070 |
Why?
|
| Blood Vessels | 1 | 2013 | 1113 | 0.070 |
Why?
|
| Spinal Cord Injuries | 1 | 2014 | 927 | 0.070 |
Why?
|
| Sleep Deprivation | 1 | 2014 | 845 | 0.070 |
Why?
|
| Probability | 3 | 2007 | 2475 | 0.070 |
Why?
|
| Choice Behavior | 1 | 2013 | 844 | 0.070 |
Why?
|
| Drug Utilization | 1 | 2012 | 1187 | 0.070 |
Why?
|
| Research Personnel | 1 | 2011 | 590 | 0.060 |
Why?
|
| Maternal-Fetal Relations | 1 | 2006 | 25 | 0.060 |
Why?
|
| Propensity Score | 4 | 2015 | 1968 | 0.060 |
Why?
|
| Perinatology | 1 | 2006 | 64 | 0.060 |
Why?
|
| Disability Evaluation | 1 | 2013 | 1820 | 0.060 |
Why?
|
| Incidence | 8 | 2018 | 21480 | 0.060 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2012 | 1514 | 0.060 |
Why?
|
| Disease Outbreaks | 1 | 2015 | 1759 | 0.060 |
Why?
|
| Sensitivity and Specificity | 6 | 2013 | 14652 | 0.060 |
Why?
|
| Mental Disorders | 2 | 2015 | 6853 | 0.060 |
Why?
|
| Safety Management | 1 | 2011 | 763 | 0.060 |
Why?
|
| Massachusetts | 6 | 2018 | 8875 | 0.060 |
Why?
|
| Osteosarcoma | 1 | 2010 | 909 | 0.060 |
Why?
|
| Genetic Counseling | 1 | 2008 | 634 | 0.060 |
Why?
|
| Cesarean Section, Repeat | 1 | 2004 | 32 | 0.060 |
Why?
|
| Confidentiality | 1 | 2008 | 607 | 0.050 |
Why?
|
| Prospective Studies | 13 | 2010 | 54802 | 0.050 |
Why?
|
| Chromium | 1 | 2004 | 132 | 0.050 |
Why?
|
| General Surgery | 1 | 1995 | 1722 | 0.050 |
Why?
|
| Medical Informatics | 1 | 2011 | 745 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2019 | 3458 | 0.050 |
Why?
|
| Unnecessary Procedures | 1 | 2007 | 416 | 0.050 |
Why?
|
| Referral and Consultation | 2 | 2015 | 3615 | 0.050 |
Why?
|
| Labor Onset | 1 | 2003 | 17 | 0.050 |
Why?
|
| Chronic Disease | 3 | 2014 | 9347 | 0.050 |
Why?
|
| Parenting | 1 | 2009 | 709 | 0.050 |
Why?
|
| Health Surveys | 1 | 2013 | 4056 | 0.050 |
Why?
|
| Receptors, Progesterone | 1 | 2008 | 1153 | 0.050 |
Why?
|
| Continuity of Patient Care | 1 | 2010 | 1078 | 0.050 |
Why?
|
| Myometrium | 2 | 2008 | 175 | 0.050 |
Why?
|
| Medicaid | 2 | 2013 | 2833 | 0.050 |
Why?
|
| Substance-Related Disorders | 1 | 2019 | 4416 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2015 | 20124 | 0.050 |
Why?
|
| Seizures | 1 | 2015 | 3000 | 0.050 |
Why?
|
| Lupus Nephritis | 1 | 2005 | 320 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 2010 | 7851 | 0.050 |
Why?
|
| Early Diagnosis | 1 | 2007 | 1187 | 0.050 |
Why?
|
| Peripartum Period | 1 | 2023 | 140 | 0.050 |
Why?
|
| Emergency Service, Hospital | 1 | 2021 | 7875 | 0.050 |
Why?
|
| Patient Readmission | 1 | 2015 | 3286 | 0.050 |
Why?
|
| Feeding Behavior | 1 | 2014 | 3212 | 0.050 |
Why?
|
| Streptococcus agalactiae | 1 | 2003 | 328 | 0.050 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2012 | 1480 | 0.050 |
Why?
|
| Case Management | 1 | 2003 | 277 | 0.050 |
Why?
|
| Embryonic and Fetal Development | 1 | 2002 | 419 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 5370 | 0.050 |
Why?
|
| Analgesics, Opioid | 1 | 2017 | 3835 | 0.050 |
Why?
|
| Dendritic Cells | 1 | 2012 | 2747 | 0.040 |
Why?
|
| Infant | 3 | 2023 | 36386 | 0.040 |
Why?
|
| Acute Coronary Syndrome | 1 | 2013 | 2184 | 0.040 |
Why?
|
| Male | 11 | 2023 | 363698 | 0.040 |
Why?
|
| Predictive Value of Tests | 4 | 2014 | 15398 | 0.040 |
Why?
|
| Electronic Health Records | 2 | 2015 | 4873 | 0.040 |
Why?
|
| Transplantation, Autologous | 1 | 2005 | 2120 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3251 | 0.040 |
Why?
|
| Harm Reduction | 1 | 2021 | 141 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 2 | 1999 | 1600 | 0.040 |
Why?
|
| Decision Support Techniques | 1 | 2010 | 2003 | 0.040 |
Why?
|
| Blood Loss, Surgical | 2 | 2015 | 629 | 0.040 |
Why?
|
| Sleep | 1 | 2015 | 4813 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2015 | 12240 | 0.040 |
Why?
|
| Hospitals | 1 | 2013 | 3888 | 0.040 |
Why?
|
| Child | 6 | 2023 | 80564 | 0.040 |
Why?
|
| Single-Blind Method | 2 | 2019 | 1589 | 0.040 |
Why?
|
| Plasma Exchange | 1 | 2020 | 160 | 0.040 |
Why?
|
| Inflammation | 3 | 2004 | 10850 | 0.040 |
Why?
|
| Fasting | 3 | 2016 | 1606 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2008 | 1874 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 3685 | 0.040 |
Why?
|
| Estradiol | 2 | 2003 | 1947 | 0.040 |
Why?
|
| HIV Infections | 2 | 1996 | 17533 | 0.040 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2021 | 258 | 0.040 |
Why?
|
| Gases | 1 | 1999 | 206 | 0.040 |
Why?
|
| Streptococcal Infections | 1 | 2003 | 617 | 0.040 |
Why?
|
| Menopause | 1 | 2007 | 1659 | 0.040 |
Why?
|
| Supine Position | 1 | 2019 | 209 | 0.040 |
Why?
|
| Cross-Over Studies | 2 | 2015 | 2108 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2023 | 65188 | 0.040 |
Why?
|
| Karyotyping | 1 | 2000 | 1178 | 0.040 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2003 | 644 | 0.040 |
Why?
|
| Thyroid Crisis | 1 | 1997 | 8 | 0.040 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1999 | 453 | 0.040 |
Why?
|
| Infant, Premature | 2 | 2004 | 2122 | 0.030 |
Why?
|
| Organ Transplantation | 1 | 2007 | 1174 | 0.030 |
Why?
|
| False Negative Reactions | 1 | 1998 | 573 | 0.030 |
Why?
|
| Life Style | 1 | 2008 | 3926 | 0.030 |
Why?
|
| Amnion | 1 | 1998 | 204 | 0.030 |
Why?
|
| Neovascularization, Physiologic | 1 | 2004 | 1375 | 0.030 |
Why?
|
| Vitamin D | 1 | 2010 | 3272 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2005 | 1602 | 0.030 |
Why?
|
| Patient Positioning | 1 | 2019 | 328 | 0.030 |
Why?
|
| Proteinuria | 2 | 2013 | 607 | 0.030 |
Why?
|
| Ovulation Induction | 1 | 1998 | 277 | 0.030 |
Why?
|
| Public Health | 1 | 2009 | 2680 | 0.030 |
Why?
|
| Canada | 1 | 2021 | 2119 | 0.030 |
Why?
|
| Age Distribution | 1 | 2001 | 2858 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2016 | 42500 | 0.030 |
Why?
|
| Testosterone | 2 | 2003 | 2494 | 0.030 |
Why?
|
| Tilt-Table Test | 1 | 2015 | 79 | 0.030 |
Why?
|
| Chorioamnionitis | 1 | 1996 | 155 | 0.030 |
Why?
|
| Hyperthyroidism | 1 | 1997 | 294 | 0.030 |
Why?
|
| Rupture | 1 | 1997 | 443 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2005 | 2056 | 0.030 |
Why?
|
| Philosophy, Medical | 1 | 1995 | 78 | 0.030 |
Why?
|
| Infant, Premature, Diseases | 1 | 2001 | 713 | 0.030 |
Why?
|
| Confidence Intervals | 2 | 2014 | 2910 | 0.030 |
Why?
|
| Neovascularization, Pathologic | 1 | 2004 | 2631 | 0.030 |
Why?
|
| Databases, Factual | 3 | 2017 | 8067 | 0.030 |
Why?
|
| Digestive System Diseases | 1 | 2015 | 151 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2010 | 4863 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 1997 | 911 | 0.030 |
Why?
|
| Methyldopa | 1 | 2013 | 19 | 0.030 |
Why?
|
| Zidovudine | 1 | 1996 | 626 | 0.030 |
Why?
|
| Labetalol | 1 | 2013 | 29 | 0.030 |
Why?
|
| Thyroxine | 1 | 1997 | 672 | 0.030 |
Why?
|
| Iodine Radioisotopes | 1 | 1997 | 1029 | 0.030 |
Why?
|
| Uterine Inertia | 1 | 2013 | 29 | 0.030 |
Why?
|
| Prognosis | 4 | 2013 | 29922 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2000 | 1394 | 0.030 |
Why?
|
| Sweden | 1 | 2016 | 1381 | 0.030 |
Why?
|
| Laparotomy | 1 | 2015 | 460 | 0.030 |
Why?
|
| Obesity | 2 | 2009 | 13076 | 0.030 |
Why?
|
| Compliance | 1 | 2013 | 100 | 0.030 |
Why?
|
| Uterine Perforation | 1 | 1992 | 4 | 0.030 |
Why?
|
| Wound Healing | 1 | 2004 | 2792 | 0.030 |
Why?
|
| Registries | 2 | 2016 | 8297 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2003 | 2243 | 0.030 |
Why?
|
| Solubility | 2 | 2004 | 1078 | 0.030 |
Why?
|
| Hypothyroidism | 1 | 1997 | 667 | 0.020 |
Why?
|
| Fetal Heart | 1 | 1994 | 281 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2013 | 11499 | 0.020 |
Why?
|
| Siblings | 1 | 2016 | 828 | 0.020 |
Why?
|
| Medically Uninsured | 1 | 2017 | 838 | 0.020 |
Why?
|
| Uric Acid | 1 | 1998 | 809 | 0.020 |
Why?
|
| Blood Component Transfusion | 1 | 1992 | 138 | 0.020 |
Why?
|
| Disease Progression | 1 | 2008 | 13632 | 0.020 |
Why?
|
| Diagnosis-Related Groups | 1 | 2013 | 445 | 0.020 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2018 | 855 | 0.020 |
Why?
|
| Thyroid Gland | 1 | 1997 | 1180 | 0.020 |
Why?
|
| Patient Admission | 1 | 2018 | 1365 | 0.020 |
Why?
|
| Regression Analysis | 2 | 1997 | 6322 | 0.020 |
Why?
|
| Hemostatic Techniques | 1 | 2011 | 115 | 0.020 |
Why?
|
| Proteins | 1 | 2005 | 5995 | 0.020 |
Why?
|
| Manometry | 1 | 2013 | 457 | 0.020 |
Why?
|
| Electromyography | 1 | 2015 | 1399 | 0.020 |
Why?
|
| HIV Seropositivity | 1 | 1996 | 961 | 0.020 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2010 | 41 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 2 | 2010 | 5526 | 0.020 |
Why?
|
| Hirschsprung Disease | 1 | 1992 | 164 | 0.020 |
Why?
|
| Chromosome Disorders | 1 | 1993 | 498 | 0.020 |
Why?
|
| Survival of Motor Neuron 1 Protein | 1 | 2010 | 64 | 0.020 |
Why?
|
| Biological Assay | 1 | 1993 | 627 | 0.020 |
Why?
|
| Diagnostic Techniques, Endocrine | 1 | 2009 | 43 | 0.020 |
Why?
|
| Vascular Resistance | 1 | 2013 | 941 | 0.020 |
Why?
|
| Blastocyst | 1 | 1993 | 432 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 2233 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 15880 | 0.020 |
Why?
|
| Polysomnography | 1 | 2015 | 1859 | 0.020 |
Why?
|
| Progesterone | 1 | 1993 | 752 | 0.020 |
Why?
|
| Immunomodulation | 1 | 2012 | 547 | 0.020 |
Why?
|
| Religion | 1 | 2011 | 376 | 0.020 |
Why?
|
| Proportional Hazards Models | 3 | 2012 | 12509 | 0.020 |
Why?
|
| Microcirculation | 1 | 2013 | 1280 | 0.020 |
Why?
|
| Arteries | 1 | 2013 | 1118 | 0.020 |
Why?
|
| Drug Costs | 1 | 1996 | 1193 | 0.020 |
Why?
|
| Limb Salvage | 1 | 2010 | 488 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2012 | 18973 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2013 | 1499 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 1993 | 1774 | 0.020 |
Why?
|
| Primary Health Care | 2 | 2015 | 4736 | 0.020 |
Why?
|
| Clinical Chemistry Tests | 1 | 2005 | 59 | 0.020 |
Why?
|
| Survival Analysis | 2 | 2013 | 10070 | 0.020 |
Why?
|
| Endometrium | 1 | 2008 | 406 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2015 | 2780 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2015 | 2334 | 0.010 |
Why?
|
| Outpatients | 1 | 2012 | 1595 | 0.010 |
Why?
|
| Artifacts | 1 | 2013 | 1893 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2015 | 2039 | 0.010 |
Why?
|
| Physician-Nurse Relations | 1 | 2003 | 20 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 1884 | 0.010 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2010 | 1737 | 0.010 |
Why?
|
| Growth Substances | 1 | 2005 | 758 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2015 | 2531 | 0.010 |
Why?
|
| Steroids | 1 | 2008 | 933 | 0.010 |
Why?
|
| Hemodynamics | 1 | 2013 | 4184 | 0.010 |
Why?
|
| Gene Expression Regulation | 2 | 2012 | 11888 | 0.010 |
Why?
|
| Microscopy, Confocal | 1 | 2008 | 1966 | 0.010 |
Why?
|
| Length of Stay | 1 | 2015 | 6485 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2010 | 6203 | 0.010 |
Why?
|
| Nephrotic Syndrome | 1 | 2005 | 380 | 0.010 |
Why?
|
| Nurse's Role | 1 | 2003 | 187 | 0.010 |
Why?
|
| Models, Statistical | 1 | 1996 | 5089 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2008 | 5020 | 0.010 |
Why?
|
| Perinatal Care | 1 | 2003 | 246 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2014 | 8733 | 0.010 |
Why?
|
| Pulsatile Flow | 1 | 2001 | 318 | 0.010 |
Why?
|
| Renal Insufficiency | 1 | 2005 | 804 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 1993 | 4209 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2015 | 6273 | 0.010 |
Why?
|
| Models, Organizational | 1 | 2003 | 547 | 0.010 |
Why?
|
| Radiography | 1 | 2010 | 6919 | 0.010 |
Why?
|
| Infant, Low Birth Weight | 1 | 2004 | 871 | 0.010 |
Why?
|
| Patient Care Team | 1 | 2010 | 2517 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 2844 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2004 | 15652 | 0.010 |
Why?
|
| Survival Rate | 1 | 2013 | 12795 | 0.010 |
Why?
|
| Infant Mortality | 1 | 2003 | 751 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2011 | 5993 | 0.010 |
Why?
|
| Heart Defects, Congenital | 1 | 2014 | 4697 | 0.010 |
Why?
|
| Diagnosis, Differential | 2 | 2005 | 12976 | 0.010 |
Why?
|
| Cytokines | 1 | 2012 | 7421 | 0.010 |
Why?
|
| Enterocolitis, Necrotizing | 1 | 2001 | 328 | 0.010 |
Why?
|
| Health Resources | 1 | 2003 | 949 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 1997 | 456 | 0.010 |
Why?
|
| Pain | 1 | 2011 | 5077 | 0.010 |
Why?
|
| Retinopathy of Prematurity | 1 | 2001 | 449 | 0.010 |
Why?
|
| Health Services Research | 1 | 2003 | 1808 | 0.010 |
Why?
|
| Morbidity | 1 | 2001 | 1749 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2010 | 4058 | 0.010 |
Why?
|
| Social Class | 1 | 2004 | 2007 | 0.010 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2003 | 953 | 0.010 |
Why?
|
| Time Factors | 2 | 2009 | 40065 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2012 | 11641 | 0.010 |
Why?
|
| Wounds, Penetrating | 1 | 1996 | 317 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2004 | 3513 | 0.010 |
Why?
|
| Mice | 2 | 2008 | 81819 | 0.010 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2005 | 2159 | 0.010 |
Why?
|
| Brain | 1 | 2000 | 27171 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2008 | 12768 | 0.010 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 1996 | 475 | 0.010 |
Why?
|
| Birth Order | 1 | 1992 | 93 | 0.010 |
Why?
|
| Aged | 2 | 2021 | 171117 | 0.010 |
Why?
|
| Kidney | 1 | 2005 | 7066 | 0.010 |
Why?
|
| ROC Curve | 1 | 1998 | 3620 | 0.010 |
Why?
|
| Medical History Taking | 1 | 1994 | 777 | 0.010 |
Why?
|
| Animals | 2 | 2008 | 168764 | 0.000 |
Why?
|
| Comorbidity | 1 | 2002 | 10563 | 0.000 |
Why?
|
| Gene Expression | 1 | 1997 | 7584 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 11022 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 36532 | 0.000 |
Why?
|
| Family | 1 | 1992 | 3209 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1997 | 59489 | 0.000 |
Why?
|